Mumbai, June 24 -- Concord Biotech has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection
carried out by them at its API facility at Dholka from 28 April 2025 till 2 May 2025.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.